Zobrazeno 1 - 10
of 221
pro vyhledávání: '"Ronald H. Laessig"'
Autor:
Inhorn, Stan
Publikováno v:
Wisconsin Medical Journal; Aug2009, Vol. 108 Issue 5, p220-220, 1p, 1 Black and White Photograph
Autor:
Ronald H. Laessig, Sharon S. Ehrmeyer
Publikováno v:
Clinics in Laboratory Medicine. 29:463-478
All clinical laboratory testing in the United States is regulated by the Clinical Laboratory Improvement Amendments of 1988 (CLIA'88 or CLIA) and overseen by the Centers for Medicare and Medicaid Services. CLIA profoundly changed the prevailing Unite
Autor:
John M. Routes, Daniel F.I. Kurtycz, Charles D. Brokopp, Ronald H. Laessig, Gary Hoffman, Murray L. Katcher, Michael F. Cogley, Mei W. Baker, Thomas J. Litsheim, William J. Grossman
Publikováno v:
Journal of Allergy and Clinical Immunology. 124:522-527
Background Severe combined immunodeficiency (SCID) is characterized by the absence of functional T cells and B cells. Without early diagnosis and treatment, infants with SCID die from severe infections within the first year of life. Objective To dete
Autor:
Sharon S. Ehrmeyer, Ronald H. Laessig
Publikováno v:
Accreditation and Quality Assurance. 13:139-144
Auditing of clinical laboratories is a recognized component of quality assurance practice. National regulatory standards, such as the U.S. Clinical Laboratory Improvement Amendments (CLIA), and international voluntary standards, such as those promulg
Autor:
Sharon S. Ehrmeyer, Ronald H. Laessig
Publikováno v:
Accreditation and Quality Assurance. 11:265-268
In the U.S., all clinical laboratory testing is regulated by the Clinical Laboratory Improvement Amendments (CLIA) (http://www.phppo.cdc.gov/clia/regs/toc.aspx). The CLIA link test quality and adherence to a body of testing regulations intended to en
Autor:
Ronald H. Laessig, Philip M. Farrell, Gary Hoffman, Michael J. Rock, Thomas J. Litsheim, Greg J. Kopish
Publikováno v:
The Journal of Pediatrics. 147:S73-S77
Objective To describe the development and follow-up confirmatory results of the routine cystic fibrosis (CF) newborn screening (NBS) program in Wisconsin. Methods CF NBS has been performed on a routine clinical basis in Wisconsin since July 1994. The
Autor:
James R. Prudent, Eric B. Roesch, Christopher B. Sherrill, Gary Madsen, Christie M. Miller, Mei W. Baker, Edward L. Beaty, Scott Johnson, Gerda Harms, Scott A. Lederer, Gary Hoffman, David J. Marshall, Greg J. Kopish, Ronald H. Laessig, Philip M. Farrell, Steven A. Benner
Publikováno v:
Clinical Chemistry
Background: All states require some kind of testing for newborns, but the policies are far from standardized. In some states, newborn screening may include genetic tests for a wide range of targets, but the costs and complexities of the newer genetic
Autor:
Sharon S. Ehrmeyer, Ronald H. Laessig
Publikováno v:
Clinica Chimica Acta. 346:37-43
Background: The Clinical Laboratory Improvement Amendments of 1988 (CLIA'88) mandate universal requirements for all U.S. clinical laboratory-testing sites. The intent of CLIA'88 is to ensure quality testing through a combination of minimum quality pr
Publikováno v:
Clinical Medicine & Research. 1:281-290
Polybrominated diphenyl ethers (PBDEs) are a class of recalcitrant and bioaccumulative halogenated compounds that have emerged as a major environmental pollutant. PBDEs are used as a flame-retardant and are found in consumer goods such as electrical
Publikováno v:
Point of Care: The Journal of Near-Patient Testing & Technology. 2:188-194